Authors:
ISAACS RCA
CUTRONA KJ
NEWTON CL
SANDERSON PEJ
SOLINSKY MG
BASKIN EP
CHEN IW
COOPER CM
COOK JJ
GARDELL SJ
LEWIS SD
LUCAS RJ
LYLE EA
LYNCH JJ
NAYLOROLSEN AM
STRANIERI MT
VASTAG K
VACCA JP
Citation: Rca. Isaacs et al., C6 MODIFICATION OF THE PYRIDINONE CORE OF THROMBIN INHIBITOR L-374,087 AS A MEANS OF ENHANCING ITS ORAL ABSORPTION, Bioorganic & medicinal chemistry letters, 8(13), 1998, pp. 1719-1724
Authors:
FABRE TS
TRELEAVEN WD
MCCARLEY TD
NEWTON CL
LANDRY RM
SARAIVA MC
STRONGIN RM
Citation: Ts. Fabre et al., THE REACTION OF BUCKMINSTERFULLERENE WITH DIAZOTETRAZOLE - SYNTHESIS,ISOLATION, AND CHARACTERIZATION OF (C-60)(2)C-2, Journal of organic chemistry, 63(11), 1998, pp. 3522-3523
Citation: Hb. Newton et Cl. Newton, ATTEMPTED DOSE INTENSIFIED CYCLOPHOSPHAMIDE, ETOPOSIDE, AND GRANULOCYTE-COLONY-STIMULATING FACTOR FOR TREATMENT OF MALIGNANT ASTROCYTOMA, Journal of neuro-oncology, 24(3), 1995, pp. 285-292
Citation: Aa. Avlicino et Cl. Newton, PROPOSAL FOR EXPERIMENTAL STUDIES TO EVALUATE SODIUM-HYPOCHLORITE DIALYSATE IN RETROVIRAL TREATMENT, Medical hypotheses, 42(3), 1994, pp. 169-172
Citation: Cl. Newton et al., COEXPRESSION IN VERTEBRATE TISSUES AND CELL-LINES OF MULTIPLE INOSITOL 1,4,5-TRISPHOSPHATE (INSP(3)) RECEPTORS WITH DISTINCT AFFINITIES FORINSP(3), The Journal of biological chemistry, 269(46), 1994, pp. 28613-28619